Company intelligence / Profile preview

SETV Global

Hyderabad, Telangana, India

Ownership: Private
Development stage: Other

Overview

SETV Global develops and manufactures chemical intermediates, APIs, building blocks, peptides, and specialized reagents to accelerate drug development for multiple therapeutic areas with rapid delivery, advanced analytics, and robust quality control.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesOncologyNeurology
Modalities: Small moleculePeptides (cyclic and acyclic)Amino acidsChemical intermediatesDiagnostic reagentImaging reagent (PET, CT, MRI)
Industry: Contract Manufacturing Organization

Partnerships

Strategic R&D partnerships with academic and industrial entities; details not specified

Beyond the preview

Go deeper on SETV Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SETV Global.

Explore the full profile